Northwestern Mutual Wealth Management
RCKT icon

Northwestern Mutual Wealth Management’s Rocket Pharmaceuticals RCKT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38
Closed -$93 – 4008
2025
Q2 		$93 Buy
+38
New +$193 ﹤0.01% 3557
2023
Q2 		– Sell
-132
Closed -$2.26K – 3560
2023
Q1 		$2.26K Buy
132
+131
+13,100% +$2.56K ﹤0.01% 2918
2022
Q4 		$20 Buy
+1
New +$18 ﹤0.01% 3278
2019
Q4 		– Sell
-150
Closed -$2K – 2580
2019
Q3 		$2K Buy
+150
New +$1.86K ﹤0.01% 2286

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Northwestern Mutual Wealth Management's RCKT Position: Q3 2025 in Review

Northwestern Mutual Wealth Management sold out of Rocket Pharmaceuticals (RCKT) in Q3 2025, closing a stake of 38 shares — an estimated $93 sold.

Northwestern Mutual Wealth Management first reported a position in RCKT in Q3 2019 and held it in 4 quarters. The position peaked at $2.26K in Q1 2023. 173 funds tracked by Wall St. Rank hold RCKT as of Q3 2025.

  • Northwestern Mutual Wealth Management reported no remaining Rocket Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 38 Rocket Pharmaceuticals shares in Q3 2025, an estimated $93.
  • Northwestern Mutual Wealth Management first reported a position in Rocket Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Rocket Pharmaceuticals position peaked at $2.26K in Q1 2023.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q3 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.